New portable device could bring glaucoma screening to remote areas

NCT ID NCT07674069

Recruiting now Diagnosis Sponsor: Buckinghamshire Healthcare NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This pilot study tests a new, portable device called the World Sight Foundation Field Machine (WSFFM) for measuring visual field loss in glaucoma patients. The WSFFM is compared to the standard Humphrey Visual Field analyzer to see if it can accurately detect glaucoma damage. If successful, the WSFFM could help doctors in lower-income countries diagnose glaucoma earlier and prevent vision loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: World Sight Foundation Field Machine (WSFFM) device
What this could lead to: If the WSFFM proves accurate and easy to use, it could enable earlier glaucoma diagnosis and treatment in lower-income countries, helping prevent irreversible vision loss.
What could go wrong: This is a small pilot study (100 participants) comparing a new device to the gold standard. The WSFFM may not match the Humphrey analyzer's accuracy, and results may not generalize to real-world settings in low-resource areas.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

Contacts and locations

Locations

Buckinghamshire Healthcare NHS Trust
RECRUITING

Aylesbury, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.